PreciseDx, Inc. — Form D
PreciseDx, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-01. The offering totals $28.2M, of which $20.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-04-01
- Form: D
- Accession: 0002013833-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $28.2M
- Amount sold: $20.7M
- Remaining: $7.5M
- Investors: 10
- Date of first sale: 2024-02-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509218
Issuer
- Name: PreciseDx, Inc.
- CIK: 0002013833
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 810 7th Avenue, NEW YORK, NY, 10019
- Phone: (646) 818-9330
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Erik Lium | Director | New York, NY |
| Westley Dupray | Director | New York, NY |
| Michael Hennessy Jr. | Director | New York, NY |
| Paul Roma | Director | New York, NY |
| Molly Harper | Director | New York, NY |
| Eric Converse | Director | New York, NY |
| Eric Converse | Executive Officer | New York, NY |
| Edward Joseph Sitar | Executive Officer | New York, NY |
| Wayne Brinster | Director | New York, NY |
| Wayne Brinster | Executive Officer | New York, NY |
Other filings by this issuer (2)
More